Skip to main content

Doxazosin Mesylate

Therapy Area
Anti-hypertensive/ Benign Prostatic Hyperplasia - BPH
API Technology
Synthetic
Formulation
Oral Solids
Development Status
Available
Available Regulatory Filing
USA
Canada
CEP
Korea
Taiwan
Brazil
Innovator Brand (US)
CARDURA

We are here to help, if you have any country specific requirements - please Contact Us.